Those who started on dapagliflozin within 12 months of their last MI had a 34% relative risk
reduction in MACE, compared with placebo, while those who enrolled 12-24 months after their last MI enjoyed an even more robust 58% relative risk
reduction on dapagliflozin.
Physician misconceptions based on patients' relative risks
of comorbidities may lead to increased cancer screenings, which "can pro vide great benefit in a proper context; however, they are not without consequences.
Deedwania used data collected in the FOURIER (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk) trial, which had showed an overall relative risk
reduction of 15% compared with placebo during a median follow-up of 2.2 years for the primary endpoint of cardiovascular death, nonfatal MI, nonfatal stroke, hospitalization for unstable angina, or coronary revascularization (N Engl J Med.
The relative risk
(r), risk difference (d), and odds ratio (9) between the groups are defined as:
were pooled using a random effects model; dose-response relations were evaluated using data from all rice intake categories in each study.
were pooled separately for the randomised and non-randomised controlled studies, using a random effects model.
The relative risk
of leukemia for children born in zone II was 0.60, corresponding to a reduction in risk of 40%.
After adjustment for age, socioeconomic status, and education, the relative risk
of hospital admission for depression for men with diabetes was 1.73; for women, it was 1.21.
Current users of combined pills had a significantly higher cancer risk than never-users (relative risk
, 1.6), and the relative risk
increased with duration of use (to 1.9 among women who had been using the pill for five or more years).
The pooled results of all 8 trials showed that folic acid supplementation, with or without additional B vitamin supplementation, significantly reduced the relative risk
of stroke by 25% in participants who did not have a history of stroke.
Some studies have estimated relative risk
aversion to be less than I (Hansen and Singleton, 1982), others obtain values that are generally between 1 and 10 (Szpiro, 1986a,1986b; Eisenhauer and Ventura, 2003), still others conclude that relative risk
aversion must be well in excess of 10 in order to explain observed behavior (Mehra and Prescott, 1985), and outliers have been reported in the hundreds (Halek and Eisenhauer, 2001).
Women exposed to the highest cumulative DES dosages in utero had the highest relative risk
of developing breast cancer.